COW

COW combines four structurally distinct peptides — Cartalax (AED), BPC-157, TB-500, and KPV — each with an independently characterized research profile. The current indexed literature evaluates these components in isolation; no peer-reviewed primary study, review, or registered trial examining the complete four-part blend as a unified formulation was identified. The research landscape described below is therefore built from individual component literatures, and no combination or synergy between components is implied by their co-formulation.

Cartalax (AED; Ala-Glu-Asp; laboratory code T-31) belongs to the family of Khavinson-class ultrashort peptide bioregulators. Primary research in this area uses cell-culture models to examine how short peptide sequences interact with nuclear structures. Khavinson et al. (2001) examined the capacity of short peptides to interact with specific DNA sequences and histone proteins, measuring the downstream gene-expression profile of structural matrix proteins in isolated cell cultures. Subsequent work from the same research group extended these models to fibroblast, renal epithelial, and mesenchymal stem-cell cultures, using immunocytochemistry and confocal microscopy to assess senescence-associated markers (p16, p21, p53, sirtuin-1, sirtuin-6, Ki-67) and extracellular-matrix remodeling endpoints (collagen I, MMP-9, MMP-14). Class-level mechanistic modeling has used molecular docking of dipeptide sequences against B-form double-stranded DNA tetranucleotide targets to characterize proposed peptide–DNA interaction geometry. The cartilage and connective-tissue research framing for Cartalax derives from proposed sequence homology with type XI collagen alpha-1 chain.

BPC-157 is a 15-amino-acid synthetic peptide whose indexed literature concentrates on connective-tissue cell biology and vascular signaling. In tendon-fibroblast models, Chang et al. (2011) used tendon explant outgrowth assays and cultured fibroblast transwell migration to examine FAK-paxillin pathway signaling alongside cell outgrowth and survival-under-oxidative-stress endpoints. Vascular research has examined angiogenesis-related assays — including endothelial tube-formation and chick chorioallantoic membrane systems — measuring VEGFR2 expression, VEGFR2–Akt–eNOS phosphorylation, and Src–Caveolin-1–eNOS coupling in endothelial preparations. A substantial review literature (Sikiric et al., 2016) surveys the BPC-157 research base across central and peripheral tissue models, including gastrointestinal mucosal preparations studied under chemically induced stress conditions; nitric-oxide system engagement is a recurring mechanistic thread across these contexts.

TB-500 in the indexed literature is characterized as an N-terminally acetylated heptapeptide (Ac-LKKTETQ) corresponding to an actin-binding motif within a larger endogenous peptide; the commercial designation and the full-length 43-residue precursor are not established as equivalent in the primary literature. Direct TB-500 papers focus on chemical identity, synthesis, and analytical detection — including liquid chromatography–mass spectrometry methodologies in equine and rodent matrices. Goldstein et al. (2005) reviewed the actin-sequestering properties and cellular migration model systems associated with this molecular class, describing how the short sequence engages G-actin monomers and how the resulting sequestration modulates the actin monomer pool available for F-actin polymerization; cytoskeletal reorganization rate and endothelial cell migration serve as the primary measurement endpoints in these assay systems.

KPV (Lys-Pro-Val) is a tripeptide whose primary research literature centers on interaction with the PepT1 (SLC15A1) intestinal peptide transporter. Dalmasso et al. (2008) used intestinal epithelial cell lines and immune cell culture alongside NF-κB reporter assays, IκB-α degradation measurements, and cytokine mRNA quantification to examine how KPV engages NF-κB and MAPK pathway components following PepT1-mediated cellular uptake; specificity was examined using a competing dipeptide and in melanocortin-receptor-deficient cell systems. Murine gastrointestinal model systems have extended this work, measuring histological and myeloperoxidase endpoints in chemically induced intestinal inflammatory models. A parallel literature examines nanoparticle and hydrogel formulation platforms — including hyaluronic-acid-functionalized systems and ROS-responsive conjugate designs — engineered to deliver KPV to PepT1-expressing intestinal epithelia and macrophages, assessed by particle-size, zeta-potential, and mucosal-penetration measurements.